Intranasal influenza-based boost vaccination for preventing SARS-CoV-2 infection Jan. 17, 2022 No Comments
Everest Medicines licenses global rights to EDDC's 3CL protease inhibitors to treat COVID-19 Jan. 14, 2022 No Comments
Novel 2-((1H-indol-3-yl)thio)-N-phenyl-acetamides as inhibitors of SARS-CoV-2 RdRp Jan. 13, 2022 No Comments
Development of haloperidol analogues as Eis inhibitors to overcome kanamycin resistance in MDR TB Jan. 13, 2022 No Comments
RSS